Patient-delivered therapy for chlamydia: Putting research into practice

Sexually Transmitted Diseases

Volumn 30, Issue 6, 2003, Pages 509-511

  Klausner, Jeffrey D ^a,b,c   Chaw, Janice K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; DOXYCYCLINE;

ADULT; ANTIBIOTIC THERAPY; CHLAMYDIASIS; COMPUTER PROGRAM; CONFERENCE PAPER; DATA ANALYSIS; EVALUATION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PATIENT DELIVERED THERAPY; REINFECTION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; STATISTICAL ANALYSIS; UNITED STATES;

ADULT; CALIFORNIA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CONTACT TRACING; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ACCEPTANCE OF HEALTH CARE; PREVENTIVE HEALTH SERVICES; SEXUAL PARTNERS;

EID: 0038278401     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200306000-00007     Document Type: Conference Paper

References (15)

1. Quinn TC, Gaydos C, Shepherd M, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996; 276:1737-1742.
2. Stamm, W. Chlamydia trachomatis infections of the adults. In: Holmes KK, Sparling PF, Mardh PA, Leoman SM, Stamm WE, Piot P, Wasserheit J. Sexually Transmitted Diseases. 3rd ed. New York: McGraw-Hill, 1999:407-422.
3. Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002; 51(RR-16):32-34.
4. Cowan FM, French R, Johnson AM. The role and effectiveness of partner notification in STD control: a review. Genitourin Med 1996; 72:247-252.
5. Whittington WL, Kent C, Kissinger P, et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: Results of a multicenter cohort study. Sex Transm Dis 2001; 28: 117-123.
6. Rietmeijer CA VBR, Judson FN, Douglas JM Jr. Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening. Sex Transm Dis 2002; 29:65-72.
7. Eng T, ed. The Hidden Epidemic. Institute of Medicine. Washington, DC: National Academy Press, 1997:59.
8. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1362-1366.
9. Golden MR, Whittington WL, Gorbach PM, et al. Partner notification for chlamydial infections among private sector clinicians in Seattle-King County: a clinician and patient survey. Sex Transm Dis 1999; 26:543-547.
10. Kissinger P, Brown R, Reed K, et al. Effectivcness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. Sex Transm Infect 1998; 74:331-333.
11. Ramstedt K, Forssman L, Johannisson G. Contact tracing in the control of genital Chlamydia trachomatis infection. Int J STD AIDS 1991;2:116-118.
12. Schillinger JA, Kissinger P, Calvet H, et al. Patient-delivered partner treatment with azithromycin to prevent repeated chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis 2003; 30:49-56.
13. Klausner JD, Kimball S, Zolt I, et al. Patient Delivered Partner Therapy at San Francisco City Clinic, 1998-1999. In: Proceedings of the 13th Meeting of the International Society for Sexually Transmitted Disease Research, Denver, CO, July, 1999.
14. Golden MR, Whittington WLH, Handsfield HH, et al. Partner management for gonococcal and chlamydia infection: expansion of public health services to a private sector and expedited sex partner treatment through a partnership with commercial pharmacies. Sex Transm Dis 2001; 28:658-665.
15. Somani J, Bhullar VB, Workowski KA, et al. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000; 181:1421-1427.